MicroQuin experiment makes it to the International Space Station
MicroQuin's protein study to be conducted on the ISS through a grant by CASIS/Boeing was launched on 7/25 aboard SpaceX CRS-18. Read more on NASA's press releases here and here, and watch the launch recording here.
MicroQuin and Scott Robinson's journey featured in Boston Globe
A glimpse into the journey that Dr. Robinson has been on to drive our technology to its current stage. Through series of personal sacrifice, Dr. Robinson has given the technology and company a chance to make a significant impact in patient lives.
MicroQuin joins prestigious LabCentral in Kendall Square, Cambridge
MicroQuin has been accepted into the highly competitive Lab Central. We intend to continue our ground breaking research at this facility and strive to make significant advances in delivering first-in-class treatments for breast cancer. Watch this space!
MicroQuin is going to space for studies in the International Space Station!
MicroQuin wins TWO grants from CASIS/BOEING under this year’s “Technology in Space” program. For the first time CASIS funded 2 projects from one company as part of its MassChallenge competition. These studies will be performed on the ISS and the data will have considerable impact on creating new scientific approaches to battling cancer.
MicroQuin was invited to present its ground-breaking technologies
MicroQuin was invited to showcase our high impact and transformational technology at Health Pioneers 2018. The conference brings together decision-makers and innovators from the pharma, biotech, insurance and public health sectors to explore new ways to collaborate and pioneer.
The 26 finalists were selected among the 128 early-stage ventures at MassChallenge Boston’s acceleration program in May. The selected companies will move into the final judging round of the MassChallenge Awards, where they’ll compete for shares of $1.5 million in equity-free prizes